Interpharm Holdings, Inc. (IPAH) Research

Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks. Established in 1984, the firm maintains its principal operations in Hauppauge, New York.

Market snapshot

Symbol
IPAH
Price
$0.00
Day change
0.00%
Market cap
$660.0
P/E ratio
-0.00x
52-week range
0.00001-0.0041
Sector
Healthcare
Industry
Medical - Pharmaceuticals

Peer companies

  • Cannabis Global, Inc. (CBGL)
  • DNAPrint Genomics, Inc. (DNAG)
  • Immunotech Laboratories, Inc. (IMMB)
  • Item 9 Labs Corp. (INLB)
  • Jack Nathan Medical Corp. (JNHMF)
  • Manhattan Scientifics, Inc. (MHTX)
  • Praxsyn Corporation (PXYN)
  • Medical Cannabis Payment Solutions, Inc. (REFG)

Open Interpharm Holdings, Inc. (IPAH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.